XOMA (XOMAP) Competitors

$25.34 0.00 (0.00%)

Closing price 05/22/2026 03:53 PM Eastern

Extended Trading

$25.38 +0.04 (+0.14%)

As of 05/22/2026 04:03 PM Eastern

XOMAP vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy XOMA stock or one of its competitors? MarketBeat compares XOMA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with XOMA include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does XOMA compare to Ainos?

Ainos (NASDAQ:AIMDW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

In the previous week, XOMA had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Ainos. Ainos' average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company	Overall Sentiment
Ainos	Neutral
XOMA	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

XOMA beats Ainos on 2 of the 2 factors compared between the two stocks.

How does XOMA compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

In the previous week, XOMA had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company	Overall Sentiment
Alvotech	Neutral
XOMA	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

Alvotech and XOMA tied by winning 1 of the 2 factors compared between the two stocks.

How does XOMA compare to Aravive?

XOMA (NASDAQ:XOMAP) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, XOMA had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Aravive. XOMA's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
XOMA	Neutral
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

XOMA and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does XOMA compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and XOMA (NASDAQ:XOMAP) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

In the previous week, XOMA had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
XOMA	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

XOMA beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does XOMA compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Biofrontera's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biofrontera	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
XOMA	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Summary

Biofrontera beats XOMA on 1 of the 1 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XOMAP vs. The Competition

Export

Metric	XOMA	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$477.13M	$6.45B	$12.34B
Dividend Yield	9.29%	3.87%	2.76%	5.28%
P/E Ratio	N/A	3.81	21.22	25.65
Price / Sales	N/A	7,288.62	553.92	86.28
Price / Cash	N/A	13.13	43.49	56.67
Price / Book	N/A	84.78	10.37	7.14
Net Income	N/A	-$96.07M	$3.57B	$335.98M
7 Day Performance	0.24%	1.01%	6.01%	3.56%
1 Month Performance	-3.02%	0.50%	3.52%	2.54%
1 Year Performance	-2.01%	64.34%	34.13%	35.05%

XOMA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XOMAP XOMA	N/A	$25.34 flat	N/A	-2.0%	$0.00	$7.65M	N/A	10	News Coverage
AIMDW Ainos	N/A	$0.06 -13.3%	N/A	-71.2%	$0.00	$18.11K	N/A	40	Positive News Gap Up
ALVOW Alvotech	N/A	$0.19 -5.1%	N/A	-89.5%	$0.00	$586.32M	N/A	4	Positive News Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 -2.9%	N/A	-77.3%	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XOMAP) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

XOMA (XOMAP) Competitors